Robert M. Levy

Active 1981–2024

98
Papers
18,263
Citations
71
h-index
96
i10-index

Citations

Citations per year for Robert M. Levy1961: 1 citations1983: 1 citations1984: 1 citations1985: 4 citations1986: 18 citations1987: 18 citations1988: 38 citations1989: 25 citations1990: 15 citations1991: 16 citations1992: 24 citations1993: 14 citations1994: 12 citations1995: 17 citations1996: 18 citations1997: 20 citations1998: 27 citations1999: 44 citations2000: 58 citations2001: 48 citations2002: 46 citations2003: 48 citations2004: 51 citations2005: 58 citations2006: 62 citations2007: 65 citations2008: 88 citations2009: 103 citations2010: 118 citations2011: 137 citations2012: 130 citations2013: 132 citations2014: 130 citations2015: 123 citations2016: 134 citations2017: 167 citations2018: 116 citations2019: 440 citations2020: 477 citations2021: 396 citations2022: 375 citations2023: 268 citations2024: 517 citations2025: 174 citations2026: 10 citations1962–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,984 citing papers, 36.2% of this breakdownUnited Kingdom: 450 citing papers, 8.2% of this breakdownGermany: 294 citing papers, 5.4% of this breakdownCanada: 266 citing papers, 4.9% of this breakdownItaly: 244 citing papers, 4.5% of this breakdownChina: 237 citing papers, 4.3% of this breakdownAustralia: 219 citing papers, 4% of this breakdownNetherlands: 183 citing papers, 3.3% of this breakdownFrance: 158 citing papers, 2.9% of this breakdownBelgium: 129 citing papers, 2.4% of this breakdownSpain: 116 citing papers, 2.1% of this breakdownSwitzerland: 96 citing papers, 1.7% of this breakdown
0%36.2%Other 20.1%

Fields

  • Medicine74.8%
  • Neuroscience10.6%
  • Immunology and Microbiology6.4%
  • Biochemistry, Genetics and Molecular Biology3.3%
  • Computer Science1.4%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Other2.9%

Topics

  • Pain Mechanisms and Treatments11.2%
  • Pain Management and Treatment6.9%
  • Musculoskeletal pain and rehabilitation5.6%
  • Transcranial Magnetic Stimulation Studies2.6%
  • Pain Management and Placebo Effect2.4%
  • Botulinum Toxin and Related Neurological Disorders2.2%
  • Other69.1%

Coauthors

All papers

Open in search
  1. Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Milan Obradović, John L. Parker, Peter Single, Nicole Soliday - The Lancet Neurology 2019 cited by 336

  2. A Comprehensive Algorithm for Management of Neuropathic Pain

    Authors: , , , , , , , - Pain Medicine 2019 cited by 399

  3. The Appropriate Use of Neurostimulation of the Spinal Cord and Peripheral Nervous System for the Treatment of Chronic Pain and Ischemic Diseases: The Neuromodulation Appropriateness Consensus Committee

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Porter McRoberts, Lawrence Poree, Joshua P. Prager, Lou Raso, Richard Rauck, Marc Russo, Brian Simpson, Konstantin V. Slavin, Peter S. Staats, Michael Stanton‐Hicks, Paul Verrills, Joshua Wellington, Kayode Williams, Richard B. North - Neuromodulation Technology at the Neural Interface 2014 cited by 586

  4. Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Pain 2016 cited by 607

  5. Chronic Back Pain Is Associated with Decreased Prefrontal and Thalamic Gray Matter Density

    Authors: , , , , , , - Journal of Neuroscience 2004 cited by 1,426

  6. Chronic Pain and the Emotional Brain: Specific Brain Activity Associated with Spontaneous Fluctuations of Intensity of Chronic Back Pain

    Authors: , , , , , , - Journal of Neuroscience 2006 cited by 769

  7. ECAP-controlled closed-loop versus open-loop SCS for the treatment of chronic pain: 36-month results of the EVOKE blinded randomized clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gerrit Gmel, Robert B. Gorman, Ian Gould, Erin Hanson, Dean M. Karantonis, Abeer Khurram, Angela Leitner, Dave Mugan, Milan Obradović, Zhonghua Ouyang, John L. Parker, Peter Single, Nicole Soliday - Regional Anesthesia & Pain Medicine 2023 cited by 89

  8. Durability of Clinical and Quality-of-Life Outcomes of Closed-Loop Spinal Cord Stimulation for Chronic Back and Leg Pain

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dean M. Karantonis, Abeer Khurram, Angela Leitner, Dave Mugan, Milan Obradović, Zhonghua Ouyang, John L. Parker, Peter Single, Nicole Soliday - JAMA Neurology 2022 cited by 97

  9. Interventional management of neuropathic pain: NeuPSIG recommendations

    Authors: , , , , , , , , , , , , , - Pain 2013 cited by 455

  10. Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update

    Authors: , , , , , , , , , , , , , , , , , , , , , - Mayo Clinic Proceedings 2010 cited by 1,323

  11. Persistent Spinal Pain Syndrome: A Proposal for Failed Back Surgery Syndrome and ICD-11

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Pain Medicine 2021 cited by 170

  12. Transcranial Magnetic Stimulation for Pain, Headache, and Comorbid Depression: INS-NANS Expert Consensus Panel Review and Recommendation

    Authors: , , , , , , , , , - Neuromodulation Technology at the Neural Interface 2020 cited by 107

  13. The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William S. Rosenberg, Michael Saulino, Peter S. Staats, Lisa Stearns, Dean Willis, Elliot S. Krames, Marc A. Huntoon, Nagy Mekhail - Neuromodulation Technology at the Neural Interface 2017 cited by 333

  14. Holistic Treatment Response: An International Expert Panel Definition and Criteria for a New Paradigm in the Assessment of Clinical Outcomes of Spinal Cord Stimulation

    Authors: , , , , , , , , , , , , , , , , , , , , , - Neuromodulation Technology at the Neural Interface 2023 cited by 55

  15. Multicenter Retrospective Study of Neurostimulation With Exit of Therapy by Explant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Neuromodulation Technology at the Neural Interface 2017 cited by 140

  16. An implantable restorative-neurostimulator for refractory mechanical chronic low back pain: a randomized sham-controlled clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert M. Levy, Jan Pieter Heemels, Sam Eldabe, for the ReActiv8-B investigators - Pain 2021 cited by 69

  17. Epidural Electrical Stimulation for Stroke Rehabilitation

    Authors: , , , , , , , - Neurorehabilitation and neural repair 2015 cited by 203

  18. Therapy Habituation at 12 Months: Spinal Cord Stimulation Versus Dorsal Root Ganglion Stimulation for Complex Regional Pain Syndrome Type I and II

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Pain 2019 cited by 68

  19. The Appropriate Use of Neurostimulation: Avoidance and Treatment of Complications of Neurostimulation Therapies for the Treatment of Chronic Pain

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Samer Narouze, Robert M. Levy, Richard B. North - Neuromodulation Technology at the Neural Interface 2014 cited by 201

  20. The Neurostimulation Appropriateness Consensus Committee (NACC): Recommendations for Surgical Technique for Spinal Cord Stimulation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fabián Piedimonte, Robert M. Levy - Neuromodulation Technology at the Neural Interface 2022 cited by 48

  21. Treatment of Refractory Low Back Pain Using Passive Recharge Burst in Patients Without Options for Corrective Surgery: Findings and Results From the DISTINCT Study, a Prospective Randomized Multicenter Controlled Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James J. Yue - Neuromodulation Technology at the Neural Interface 2023 cited by 39

  22. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Results from a randomized, multicenter, double-blinded, controlled study

    Authors: , , , , , , , , , , , , , , , , , , - Cephalalgia 2012 cited by 295

  23. Breast Safety and Efficacy of Genistein Aglycone for Postmenopausal Bone Loss: A Follow-Up Study

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2008 cited by 168

  24. Prospective, Multicenter, Randomized, Double-Blinded, Partial Crossover Study to Assess the Safety and Efficacy of the Novel Neuromodulation System in the Treatment of Patients With Chronic Pain of Peripheral Nerve Origin

    Authors: , , , , , , , , , , , , , , , - Neuromodulation Technology at the Neural Interface 2016 cited by 161